Literature DB >> 11796608

Endogenous pro- and anti-inflammatory cytokines differentially regulate an in vivo humoral response to Streptococcus pneumoniae.

Abdul Q Khan1, Yi Shen, Zheng-Qi Wu, Thomas A Wynn, Clifford M Snapper.   

Abstract

Proinflammatory cytokines play a critical role in innate host defense against extracellular bacteria. However, little is known regarding the effects of these cytokines on the adaptive humoral response. Mice injected with a neutralizing anti-tumor necrosis factor alpha (TNF-alpha) monoclonal antibody (MAb) at the time of primary immunization with intact Streptococcus pneumoniae (strain R36A) showed a substantial reduction in both the primary immunoglobulin G (IgG) response specific for the cell wall protein, pneumococcal surface protein A (PspA), as well as in the development of PspA-specific memory. In contrast, anti-TNF-alpha MAb injected only at the time of secondary immunization with R36A failed to alter the boosted anti-PspA response. TNF-alpha was required only within the first 48 to 72 h after primary immunization with R36A and was induced both by non-B and non-T cells and by lymphoid cells, within 2 to 6 h after immunization, with levels returning to normal by 24 h. Thus, the early innate release of TNF-alpha was critical for optimal stimulation of the subsequent adaptive humoral response to R36A. Additional proinflammatory (interleukin 1 [IL-1], IL-6, IL-12, and gamma interferon [IFN-gamma]) as well as anti-inflammatory (IL-4 and IL-10) cytokines were also transiently induced. Mice genetically deficient in IL-6, IFN-gamma, or IL-12 also showed a reduced IgG anti-PspA response of all IgG isotypes. In contrast, IL-4(-/-) and IL-10(-/-) mice immunized with R36A showed a significant elevation in the IgG anti-PspA response, except that there was decreased IgG1 in IL-4(-/-) mice. In this regard, a marked enhancement in the induction of proinflammatory cytokines was observed in the absence of IL-10, relative to controls. Ig isotype titers specific for the phosphorycholine determinant of C-polysaccharide were similarly regulated, but to a much more modest degree. These data suggest that proinflammatory and anti-inflammatory cytokines differentially regulate an in vivo protein- and polysaccharide-specific Ig response to an extracellular bacteria.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11796608      PMCID: PMC127731          DOI: 10.1128/IAI.70.2.749-761.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  83 in total

1.  IL-10 directly acts on T cells by specifically altering the CD28 co-stimulation pathway.

Authors:  A Joss; M Akdis; A Faith; K Blaser; C A Akdis
Journal:  Eur J Immunol       Date:  2000-06       Impact factor: 5.532

Review 2.  Interleukin-4 production in response to infection with intracellular bacteria.

Authors:  H Collins; I E Flesch; M Emoto; S H Kaufmann
Journal:  Adv Exp Med Biol       Date:  1998       Impact factor: 2.622

3.  IL-4 down-regulates IL-1 and TNF gene expression in human monocytes.

Authors:  R Essner; K Rhoades; W H McBride; D L Morton; J S Economou
Journal:  J Immunol       Date:  1989-06-01       Impact factor: 5.422

Review 4.  Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity.

Authors:  G Trinchieri
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

5.  Enhanced dendritic cell maturation by TNF-alpha or cytidine-phosphate-guanosine DNA drives T cell activation in vitro and therapeutic anti-tumor immune responses in vivo.

Authors:  C Brunner; J Seiderer; A Schlamp; M Bidlingmaier; A Eigler; W Haimerl; H A Lehr; A M Krieg; G Hartmann; S Endres
Journal:  J Immunol       Date:  2000-12-01       Impact factor: 5.422

6.  IL-6-deficient mice exhibit normal mucosal IgA responses to local immunizations and Helicobacter felis infection.

Authors:  A K Bromander; L Ekman; M Kopf; J G Nedrud; N Y Lycke
Journal:  J Immunol       Date:  1996-06-01       Impact factor: 5.422

7.  NK1.1+ CD4+ CD8- thymocytes with specific lymphokine secretion.

Authors:  H Arase; N Arase; K Nakagawa; R A Good; K Onoé
Journal:  Eur J Immunol       Date:  1993-01       Impact factor: 5.532

8.  Alleviation of lipopolysaccharide-induced acute liver injury in Propionibacterium acnes-primed IFN-gamma-deficient mice by a concomitant reduction of TNF-alpha, IL-12, and IL-18 production.

Authors:  H Tsuji; N Mukaida; A Harada; S Kaneko; E Matsushita; Y Nakanuma; H Tsutsui; H Okamura; K Nakanishi; Y Tagawa; Y Iwakura; K Kobayashi; K Matsushima
Journal:  J Immunol       Date:  1999-01-15       Impact factor: 5.422

9.  The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli.

Authors:  K Inaba; S Turley; T Iyoda; F Yamaide; S Shimoyama; C Reis e Sousa; R N Germain; I Mellman; R M Steinman
Journal:  J Exp Med       Date:  2000-03-20       Impact factor: 14.307

10.  Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes.

Authors:  M Kobayashi; L Fitz; M Ryan; R M Hewick; S C Clark; S Chan; R Loudon; F Sherman; B Perussia; G Trinchieri
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

View more
  40 in total

1.  Immunization with Pneumococcal Surface Protein K of Nonencapsulated Streptococcus pneumoniae Provides Protection in a Mouse Model of Colonization.

Authors:  Lance E Keller; Xiao Luo; Justin A Thornton; Keun-Seok Seo; Bo Youn Moon; D Ashley Robinson; Larry S McDaniel
Journal:  Clin Vaccine Immunol       Date:  2015-08-26

2.  Both innate immunity and type 1 humoral immunity to Streptococcus pneumoniae are mediated by MyD88 but differ in their relative levels of dependence on toll-like receptor 2.

Authors:  Abdul Q Khan; Quanyi Chen; Zheng-Qi Wu; James C Paton; Clifford M Snapper
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

3.  TLR2 synergizes with both TLR4 and TLR9 for induction of the MyD88-dependent splenic cytokine and chemokine response to Streptococcus pneumoniae.

Authors:  Katherine S Lee; Charles A Scanga; Eric M Bachelder; Quanyi Chen; Clifford M Snapper
Journal:  Cell Immunol       Date:  2007-05-22       Impact factor: 4.868

Review 4.  Toll-like receptors--sentries in the B-cell response.

Authors:  Isabelle Bekeredjian-Ding; Gaetan Jego
Journal:  Immunology       Date:  2009-11       Impact factor: 7.397

5.  Pneumococcal surface protein A (PspA) is effective at eliciting T cell-mediated responses during invasive pneumococcal disease in adults.

Authors:  L Baril; J Dietemann; M Essevaz-Roulet; L Béniguel; P Coan; D E Briles; B Guy; G Cozon
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

6.  Association of CD14 promoter polymorphism with otitis media and pneumococcal vaccine responses.

Authors:  S P Wiertsema; S-K Khoo; G Baynam; R H Veenhoven; I A Laing; G A Zielhuis; G T Rijkers; J Goldblatt; P N Lesouëf; E A M Sanders
Journal:  Clin Vaccine Immunol       Date:  2006-08

7.  Differential activation of the immune system by virulent Streptococcus pneumoniae strains determines recovery or death of the host.

Authors:  Y Mizrachi-Nebenzahl; S Lifshitz; R Teitelbaum; S Novick; A Levi; D Benharroch; E Ling; R Dagan
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

Review 8.  What does tympanostomy tube placement in children teach us about the association between atopic conditions and otitis media?

Authors:  Young J Juhn; Chung-Il Wi
Journal:  Curr Allergy Asthma Rep       Date:  2014-07       Impact factor: 4.806

9.  Helper T cell epitope-mapping reveals MHC-peptide binding affinities that correlate with T helper cell responses to pneumococcal surface protein A.

Authors:  Rajesh Singh; Shailesh Singh; Praveen K Sharma; Udai P Singh; David E Briles; Susan K Hollingshead; James W Lillard
Journal:  PLoS One       Date:  2010-02-25       Impact factor: 3.240

10.  Characterization of protective mucosal and systemic immune responses elicited by pneumococcal surface protein PspA and PspC nasal vaccines against a respiratory pneumococcal challenge in mice.

Authors:  D M Ferreira; M Darrieux; D A Silva; L C C Leite; J M C Ferreira; P L Ho; E N Miyaji; M L S Oliveira
Journal:  Clin Vaccine Immunol       Date:  2009-03-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.